Summary of the 2026 Semi-Annual Report of Qingdao Weilan Biological Co., Ltd.
Company code: 603739 Company abbreviation: Azure Biotechnology
Summary of the semi-annual report of Qingdao Weilan Biological Co., Ltd.
2026
Summary of the 2026 Semi-Annual Report of Qingdao Weilan Biological Co., Ltd.
Section 1 Important Tips
1.1 This summary of the semi-annual report is derived from the full text of the semi-annual report. It provides a comprehensive understanding of the company’s operating results, financial status and future development.
For development planning, investors should go to the website www.sse.com.cn to carefully read the full text of the semi-annual report.
1.2 The company’s board of directors, directors and senior managers guarantee the authenticity, accuracy and completeness of the contents of the semi-annual report.
We shall bear individual and joint legal liability for false records, misleading statements or major omissions.
1.3 All directors of the company shall attend the board meeting.
1.4 This semi-annual report has not been audited.
1.5 The profit distribution plan for the reporting period or the plan for converting public reserve funds into share capital passed by the board of directors
Not applicable
Section 2 Basic Information of the Company
2.1 Company Profile
Company Stock Profile
Stock type Stock listing exchange Stock abbreviation Stock code Stock abbreviation before change A shares Shanghai Stock Exchange Azure Biotech 603739 Not applicable
Contact person
Secretary of the Board of Directors Securities Affairs Representative
system
Name Jiang Yong Liu Tingting
Phone 0532-88978071 0532-88978071
Office address No. 596-1, Jiushui East Road, Laoshan District, Qingdao City, Shandong Province No. 596-1, Jiushui East Road, Laoshan District, Qingdao City, Shandong Province
Email [email protected] [email protected]
2.2 Main financial data
Unit: Yuan Currency: RMB
The end of the reporting period is higher than the end of the reporting period compared with the end of the previous year
Year-end increase or decrease (%) Total assets 3,015,917,274.90 3,039,659,299.32 -0.78 Net assets attributable to shareholders of listed companies 1,795,784,289.24 1,782,521,319.49 0.74 This reporting period compared with the previous year This reporting period The same period last year
Increase or decrease in the same period (%) Operating income 709,615,819.06 652,193,328.83 8.80 Total profit 68,841,181.97 53,074,950.17 29.71 Net profit attributable to shareholders of listed companies 38,559,770.52 26,716,293.11 44.33
Summary of the 2026 Semi-Annual Report of Qingdao Weilan Biological Co., Ltd.
Deductions attributable to shareholders of listed companies are not
22,164,324.36 16,002,005.78 38.51 Net profit from recurring gains and losses
Net cash flow generated from operating activities 56,294,173.54 10,125,631.53 455.96 Weighted average return on equity (%) 2.16 1.53 Increased by 0.63 percentage points Basic earnings per share (yuan/share) 0.15 0.11 36.36 Diluted earnings per share (yuan/share) 0.15 0.11 36.36
2.3 List of shareholdings of the top 10 shareholders
Unit: Shares Total number of shareholders (households) as of the end of the reporting period 16,971 Total number of preference shareholders (households) whose voting rights have been restored as of the end of the reporting period Not applicable Shareholding status of the top 10 shareholders
Limited holding
Shareholding ratio Shareholding Pledged, marked or frozen name of shareholder Nature of shareholder Conditions for sale
Example (%) Number of shares of quantity
Number of shares
Qingdao Kangdien Industrial Co., Ltd.
Domestic non-state-owned legal persons 44.42 112,407,400 0 None 0 Limited company
Tibet Strong Investment Consulting
Domestic non-state-owned legal persons 7.03 17,775,520 0 None 0 Limited company
Tibet Shancheng Investment Consulting
Domestic non-state-owned legal persons 7.03 17,775,520 0 None 0 Limited company
Jia Deqiang Domestic natural person 2.81 7,103,760 0 Pledge 1,700,000 Chen Gang Domestic natural person 1.47 3,709,560 0 None 0Beijing Kangyu Technology Co., Ltd.
Domestic non-state-owned legal persons 1.38 3,480,000 0 None 0 Company
Wu Jinyuan Domestic natural person 1.32 3,351,080 0 None 0 China Merchants Fund Management Co., Ltd.
Company - Social Security Fund Others 0.91 2,300,000 0 None 0 1903 portfolio
Zheshang Bank Co., Ltd.
Company-Cathay CSI Livestock
Animal husbandry trading open Others 0.88 2,222,100 0 None 0-type index securities investment fund
gold
Industrial Securities Co., Ltd.
Company - Bodao Jiuhang Mixed Others 0.51 1,296,600 0 None 0 Combined securities investment fund
Explanation of the related relationships or concerted actions among the above-mentioned shareholders of Tibet Shancheng Investment Consulting Co., Ltd. and Tibet Strong Investment Consulting Co., Ltd. The company and Qingdao Kangdien Industrial Co., Ltd. constitute persons acting in concert;
Beijing Kangyu Technology Co., Ltd. is a company controlled by Chen Gang.
Preferred shareholders with restored voting rights and number of shares held
None
description
Summary of the 2026 Semi-Annual Report of Qingdao Weilan Biological Co., Ltd.
2.4 The total number of preference shareholders and the top 10 preference shareholders as of the end of the reporting period □ Applicable √ Not applicable
2.5 Changes in controlling shareholders or actual controllers
□Applicable √Not applicable
2.6 Status of bonds existing on the date of approval of the semi-annual report
□Applicable √Not applicable
Section 3 Important Matters
The company shall, in accordance with the principle of materiality, explain the major changes in the company's operating conditions during the reporting period, as well as the matters that occurred during the reporting period that have a significant impact on the company's operating conditions and are expected to have a significant impact in the future.
□Applicable √Not applicable